Literature DB >> 25075853

Dihydroartemisinin-piperaquine failure in Cambodia.

David L Saunders1, Pattaraporn Vanachayangkul, Chanthap Lon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25075853     DOI： 10.1056/NEJMc1403007

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  123 in total

Review 1.  Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.

Authors:  Benjamin Blasco; Didier Leroy; David A Fidock
Journal:  Nat Med       Date:  2017-08-04       Impact factor: 53.440

2.  Characterization of the Preclinical Pharmacology of the New 2-Aminomethylphenol, JPC-3210, for Malaria Treatment and Prevention.

Authors:  Geoffrey W Birrell; Gavin D Heffernan; Guy A Schiehser; John Anderson; Arba L Ager; Pablo Morales; Donna MacKenzie; Karin van Breda; Marina Chavchich; Laura R Jacobus; G Dennis Shanks; David P Jacobus; Michael D Edstein
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

3.  Piperaquine Population Pharmacokinetics and Cardiac Safety in Cambodia.

Authors:  Pattaraporn Vanachayangkul; Chanthap Lon; Michele Spring; Sommethy Sok; Winita Ta-Aksorn; Chanikarn Kodchakorn; Sut-Thang Pann; Soklyda Chann; Mali Ittiverakul; Sabaithip Sriwichai; Nillawan Buathong; Worachet Kuntawunginn; Mary So; Theng Youdaline; Erin Milner; Mariusz Wojnarski; Charlotte Lanteri; Jessica Manning; Satharath Prom; Mark Haigney; Louis Cantilena; David Saunders
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

4.  Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa.

Authors:  Changsheng Deng; Bo Huang; Qi Wang; Wanting Wu; Shaoqin Zheng; Hongying Zhang; Di Li; Danghong Feng; Guoming Li; Linlu Xue; Tao Yang; Fei Tuo; Fouad Mohadji; Xin-Zhuan Su; Qin Xu; Zhibing Wu; Li Lin; Jiuyao Zhou; Hong Yan; Affane Bacar; Kamal Said Abdallah; Rachadi A Kéké; Ahamada Msa Mliva; Moussa Mohamed; Xinhua Wang; Shiguang Huang; Fatihou Oithik; Xiao-Bo Li; Fangli Lu; Michael P Fay; Xiao-Hong Liu; Thomas E Wellems; Jianping Song
Journal:  Clin Infect Dis       Date:  2018-11-13       Impact factor: 9.079

Review 5.  Plasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.

Authors:  Valentine Duru; Benoit Witkowski; Didier Ménard
Journal:  Am J Trop Med Hyg       Date:  2016-10-17       Impact factor: 2.345

6.  Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains.

Authors:  Monika Chugh; Christian Scheurer; Sibylle Sax; Elizabeth Bilsland; Donelly A van Schalkwyk; Kathryn J Wicht; Natalie Hofmann; Anil Sharma; Sridevi Bashyam; Shivendra Singh; Stephen G Oliver; Timothy J Egan; Pawan Malhotra; Colin J Sutherland; Hans-Peter Beck; Sergio Wittlin; Thomas Spangenberg; Xavier C Ding
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

7.  Artemisinin Resistance-Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010-2015.

Authors:  Costanza Tacoli; Prabhanjan P Gai; Claude Bayingana; Kevin Sifft; Dominik Geus; Jules Ndoli; Augustin Sendegeya; Jean Bosco Gahutu; Frank P Mockenhaupt
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345

8.  Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model.

Authors:  Juliana M Sá; Sarah R Kaslow; Michael A Krause; Viviana A Melendez-Muniz; Rebecca E Salzman; Whitney A Kite; Min Zhang; Roberto R Moraes Barros; Jianbing Mu; Paul K Han; J Patrick Mershon; Christine E Figan; Ramoncito L Caleon; Rifat S Rahman; Tyler J Gibson; Chanaki Amaratunga; Erika P Nishiguchi; Kimberly F Breglio; Theresa M Engels; Soundarapandian Velmurugan; Stacy Ricklefs; Judith Straimer; Nina F Gnädig; Bingbing Deng; Anna Liu; Ababacar Diouf; Kazutoyo Miura; Gregory S Tullo; Richard T Eastman; Sumana Chakravarty; Eric R James; Kenneth Udenze; Suzanne Li; Daniel E Sturdevant; Robert W Gwadz; Stephen F Porcella; Carole A Long; David A Fidock; Marvin L Thomas; Michael P Fay; B Kim Lee Sim; Stephen L Hoffman; John H Adams; Rick M Fairhurst; Xin-Zhuan Su; Thomas E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-19       Impact factor: 11.205

9.  ATPase activity of Plasmodium falciparum MLH is inhibited by DNA-interacting ligands and dsRNAs of MLH along with UvrD curtail malaria parasite growth.

Authors:  Mohammed Tarique; Manish Chauhan; Renu Tuteja
Journal:  Protoplasma       Date:  2016-09-14       Impact factor: 3.356

10.  Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.

Authors:  Patrick Tumwebaze; Melissa D Conrad; Andrew Walakira; Norbert LeClair; Oswald Byaruhanga; Christine Nakazibwe; Benjamin Kozak; Jessica Bloome; Jaffer Okiring; Abel Kakuru; Victor Bigira; James Kapisi; Jennifer Legac; Jiri Gut; Roland A Cooper; Moses R Kamya; Diane V Havlir; Grant Dorsey; Bryan Greenhouse; Samuel L Nsobya; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.